|
Market Closed -
Australian S.E.
14:10:32 16/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.0100 AUD | 0.00% |
|
-9.09% | -33.33% |
| 08-26 | Acrux Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-25 | Acrux Limited Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 5.9M 4.21M 3.64M 3.44M 3.12M 5.85M 403M 41.11M 15.81M 205M 15.8M 15.45M 652M | P/E 2025 |
-0.95x | P/E 2026 | -8.4x |
|---|---|---|---|---|---|
| Enterprise Value | 6.71M 4.79M 4.14M 3.92M 3.55M 6.66M 459M 46.77M 17.99M 233M 17.97M 17.58M 742M | EV / Sales 2025 |
2.07x | EV / Sales 2026 | 1.08x |
| Free-Float |
95.37% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| ACR | Delayed | |
OTC Markets
| ARUXF | Delayed | |
Deutsche Boerse AG
| FJY | Delayed |
Last Transcript: Acrux Limited
| 23/05/22 | Acrux : Application for quotation of securities - ACR | PU |
| 14/04/22 | Acrux : Application for quotation of securities - ACR | PU |
| 16/03/22 | Acrux : Application for quotation of securities - ACR | PU |
| 25/02/22 | Acrux : Updated Board Charter | PU |
| 25/02/22 | Acrux : Application for quotation of securities - ACR | PU |
| 1 week | -9.09% | ||
| Current month | -4.76% | ||
| 3 months | -41.18% | ||
| 6 months | -16.67% | ||
| Current year | -33.33% |
| 1 week | 0.01 | 0.01 | |
| 1 month | 0.01 | 0.01 | |
| Current year | 0.01 | 0.02 | |
| 1 year | 0.01 | 0.02 | |
| 3 years | 0.01 | 0.1 | |
| 5 years | 0.01 | 0.13 | |
| 10 years | 0.01 | 0.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Warmbrunn
CEO | Chief Executive Officer | - | 01/06/2025 |
Joanna Johnson
DFI | Director of Finance/CFO | - | 21/06/2021 |
Jolanta Airey
CTO | Chief Tech/Sci/R&D Officer | - | 24/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Ross Dobinson
CHM | Chairman | 74 | 01/01/2006 |
Timothy Oldham
BRD | Director/Board Member | - | 01/10/2013 |
Geoff Brooke
BRD | Director/Board Member | 70 | 01/06/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -9.09% | -33.33% | -76.74% | 4.21M | ||
| +1.01% | -0.61% | +15.09% | +61.50% | 45.9B | ||
| -4.55% | -6.60% | +28.67% | +95.78% | 38.7B | ||
| +0.77% | -1.77% | +7.06% | +72.13% | 11.43B | ||
| +0.52% | -0.37% | -12.89% | +9.47% | 11.38B | ||
| -0.95% | 0.00% | +19.82% | +146.45% | 9.09B | ||
| -0.55% | +0.48% | +27.74% | +36.57% | 7.3B | ||
| +1.61% | -1.03% | +16.03% | +183.01% | 6.98B | ||
| -1.00% | -0.98% | +33.68% | -20.38% | 7.13B | ||
| -2.15% | -4.76% | -44.26% | +4.59% | 4.89B | ||
| Average | -0.53% | -2.02% | +5.76% | +51.24% | 14.28B | |
| Weighted average by Cap. | -0.94% | -2.68% | +15.79% | +71.53% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 4.49M 3.2M 2.77M 2.62M 2.37M 4.45M 307M 31.29M 12.04M 156M 12.02M 11.76M 496M | 6.58M 4.69M 4.07M 3.84M 3.48M 6.53M 450M 45.87M 17.65M 228M 17.63M 17.24M 728M |
| Net income | -5.94M -4.24M -3.67M -3.47M -3.14M -5.9M -407M -41.44M -15.94M -206M -15.93M -15.57M -658M | -604K -431K -373K -353K -319K -599K -41.32M -4.21M -1.62M -20.95M -1.62M -1.58M -66.82M |
| Net Debt | 2.77M 1.98M 1.71M 1.62M 1.47M 2.75M 190M 19.32M 7.43M 96.15M 7.43M 7.26M 307M | 813K 580K 502K 475K 430K 807K 55.62M 5.67M 2.18M 28.2M 2.18M 2.13M 89.94M |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/09/26 | A$0.0100 | 0.00% | 1,000,000 |
| 15/09/26 | A$0.0100 | -9.09% | 325,000 |
| 09/09/26 | A$0.0110 | 0.00% | 2,843,866 |
| 08/09/26 | A$0.0110 | 0.00% | 388,905 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ACR Stock
Select your edition
All financial news and data tailored to specific country editions

















